I-REMOVETM
I-REMOVETM, licence 80069407: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Litramine FatbinderTM, bmiSMART
- Licence holder
- Bionexus LLC
- NPN or DIN-HM
- 80069407
- Status
- Active licence
- Licence date
- 13 May 2016
- Revision date
- 11 September 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gamma-cyclodextrin | 85.0 milligramme | Not calculated |
| Opuntia ficus-indica Source : Feuille | 300.0 milligramme | Not calculated |
| Acacia Source : Acacia gum | 115.0 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Croscarmellose de sodium, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Comprimé | 3.0 Tous les jours |
Uses authorised in Canada
Helps to support weight management when used with a calorie-reduced diet and regular physical activity. I-RemoveTM Litramine FatbinderTM is clinically tested to be effective in weight management when used in combination with a calorie reduced diet and regular physical exercise. I-RemoveTM Litramine FatbinderTM helps to support weight management by reducing fat absorption when used in conjunction with a calorie reduced diet and regular physical exercise.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not take this product during pregnancy or while breastfeeding/nursing; or if your BMI (Body Mass Index) is below 18.5 As this product contains fibers, it is recommended that you take at least 8 glasses of water a day to avoid any possibility of constipation or stomach discomfort. If any of these conditions persist, please consult your physician. This product contains trace amounts of oxalic acids, which are found in many other green vegetables. If you have kidney disease or kidney stones, avoid taking this product on a regular basis. Consult your healthcare professional before taking this product if you have any existing medical conditions or taking any medications. If you have difficulty swallowing, consult a health care practitioner prior to use. If you have inflammatory or other chronic bowel diseases, consult your doctor prior to use.
Source
Official Health Canada record, licence 80069407
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.